Zhengjun Yi

中国科学家在线 ORCID

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 4

Top Topics

Pulmonary Tuberculosis

Dna Damage Response

Top Venues

Journal of cellular and molecular medicine

BioMed research international

Evidence-based complementary and alternative medicine : eCAM

This page only lists publications with an associated author ORCID identifier.

Publications

Jiao Gao, Chonghui Li, Wenjing Li, Haotian Chen, Yu-Rong Fu, Zhengjun Yi
Increased UBE2L6 regulated by type 1 interferon as potential marker in TB. Journal of cellular and molecular medicine 25 (24) (2021)
Binbin Yang, David Good, Tamim Mosaiab, Wei Liu, Guoying Ni, Jasmine Kaur, Xiaosong Liu, Calvin Jessop, Lu Yang, Rushdi Fadhil, Zhengjun Yi, Ming Q Wei
Significance of LL-37 on Immunomodulation and Disease Outcome. BioMed research international 2020 (2020)
Wei Liu, Binbin Yang, Lu Yang, Jasmine Kaur, Calvin Jessop, Rushdi Fadhil, David Good, Guoying Ni, Xiaosong Liu, Tamim Mosaiab, Zhengjun Yi, Ming Q Wei
Therapeutic Effects of Ten Commonly Used Chinese Herbs and Their Bioactive Compounds on Cancers. Evidence-based complementary and alternative medicine : eCAM 2019 (2019)
Qiulu Yuan, Haotian Chen, Yuxin Yang, Yu-Rong Fu, Zhengjun Yi
miR-18a promotes Mycobacterial survival in macrophages via inhibiting autophagy by down-regulation of ATM. Journal of cellular and molecular medicine 24 (2) (2019)